Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

997117

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Crohn's Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve treatment for people with Crohn's disease.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	184958
answer	answer is ministerial correction date of answer 02/11/2018 answer text <p>The National Institute for Health and Care Excellence guidance ‘Crohn’s Disease Management in Adults, Children and Young People’, updated in 2016, sets out best practice in the diagnosis, treatment care and support of patients with the condition.</p><p> </p><p>Management options include drug therapy, dietary and lifestyle advice and, in severe or chronic active disease, surgery. The aim when treating Crohn’s disease is either to heal the inflammation and so reduce symptoms during a flare‑up ('inducing remission') or to prevent flare‑ups happening in the future ('maintaining remission'). Drug treatments can include steroids, immunosuppressants and biological medicines. For patients requiring complex surgery, NHS England specialised colorectal services nationally to support equity of access to high quality treatment for patients with Crohn’s disease.</p><p> </p><p>Since 2006, the Inflammatory bowel disease (IBD) audit programme has supported work to improving the care of people with IBD. Crohn’s and ulcerative colitis are collectively known as IBD. Evidence of improvements in care during the time of the programme included the effective demonstration that biological therapies for the treatment of IBD are safe and effective drugs as well as wider improvement to support that patients received.</p><p> </p><p>The IBD audit programme was commissioned by the Healthcare Quality Improvement Partnership, on behalf on NHS England, as part of the National Clinical Audit and Patient Outcomes Programme. The programme ended in March 2017 and its quality improvement initiatives have been transferred to the United Kingdom IBD Registry as the future vehicle for IBD audit and quality improvement.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 02/11/2018 13:21:13 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

997118

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fibromyalgia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of people with fibromyalgia in each of the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	184959
answer	answer is ministerial correction date of answer 02/11/2018 answer text <p>This information is not collected.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 02/11/2018 13:13:49 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

997139

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	National Emergency Pressures Panel
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many times the national emergency pressures panel has met during the 2018-19 financial year.
tabling member constituency	Dewsbury
tabling member printed	Paula Sherriff
uin	184974
answer	answer is ministerial correction date of answer 01/11/2018 answer text <p>The National Escalation Pressures Panel (NEPP) has not yet formally met in the 2018-19 financial year.</p><p> </p><p>NHS England publishes meeting notes online when NEPP meets. These can be located on their website at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/national-emergency-pressures-panel-nepp/" target="_blank">https://www.england.nhs.uk/national-emergency-pressures-panel-nepp/</a></p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 01/11/2018 17:44:58 answering member 4095 label Biography information for Steve Barclay
tabling member	4426 label Biography information for Paula Sherriff

997151

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the quality of care provision for people with diabetes in (a) NHS Coventry and Rugby Clinical Commissioning Group and (b) England.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	184864
answer	answer is ministerial correction date of answer 01/11/2018 answer text <p>There are two Clinical Commissioning Group Improvement and Assessment Framework (CCG IAF) indicators on which CCGs are given a Red, Amber or Green rating. Ratings are combined to give an overall diabetes rating for individual CCGs. The indicators are as follows:</p><p>- Diabetes patients that have achieved all the National Institute for Health and Care Excellence (NICE) recommended treatment targets: three (HbA1c, cholesterol and blood pressure) for adults and one (HbA1c) for children; and</p><p>- People with diabetes diagnosed less than a year ago who attend a structured education course.</p><p> </p><p>The overall diabetes rating for Coventry and Rugby CCG in the most recent 2016/17 assessment was ‘Requires Improvement’, following a Green rating for patients achieving all the NICE recommended treatment targets and a Red rating for attendances at structured education courses.</p><p> </p><p>CCGs across England received the following overall ratings in relation to diabetes:</p><p>- Outstanding - 40 CCGs;</p><p>- Good - 46 CCGs;</p><p>- Requires Improvement - 102 CCGs; and</p><p>- Inadequate - 19 CCGs.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 01/11/2018 17:00:53 answering member 4067 label Biography information for Steve Brine
tabling member	308 label Biography information for Mr Jim Cunningham

997153

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent discussions he has had with NHS England on the list of medical conditions that entitle people to medical exemption certificates; and whether he plans to include additional medical conditions on that list.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	184866
answer	answer is ministerial correction date of answer 01/11/2018 answer text <p>The Department has no current plans to review or amend the list of medical conditions that provide exemption from prescription charges because arrangements exist to ensure that prescriptions are affordable for everyone. Accordingly, no recent discussions about this matter have taken place at Ministerial level with NHS England.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 01/11/2018 16:57:25 answering member 4067 label Biography information for Steve Brine
tabling member	308 label Biography information for Mr Jim Cunningham

997156

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cervical Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether GP’s have authority to request cervical cancer smear tests when patients under 25 show symptoms of cervical cancer.
tabling member constituency	Eddisbury
tabling member printed	Antoinette Sandbach
uin	184977
answer	answer is ministerial correction date of answer 01/11/2018 answer text <p>As part of the delivery of essential medical services under the General Medical Services Contract Regulations, general practitioner practices must offer consultation and, where appropriate, physical examination for the purposes of identifying the need, if any, for treatment or further investigation. Practices should carry out treatment or further investigation as is necessary and appropriate, including the referral of a patient to other services or other health care professionals.</p><p> </p><p>Patients aged over 25 are, of course, eligible for the cervical screening programme.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 01/11/2018 16:54:14 answering member 4067 label Biography information for Steve Brine
tabling member	4506 label Biography information for Antoinette Sandbach

997164

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, on what date CAR-T therapy for adult cancer patients will be made available.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	184984
answer	answer is ministerial correction date of answer 01/11/2018 answer text <p>NHS England is working with the manufacturers and National Health Service providers to prepare the NHS to begin delivering Chimeric Antigen Receptor T Cell (CAR-T) therapy - the first in a wave of treatments in a new era of personalised medicine and part of the NHS’s long-term plan to upgrade cancer service. The first treatment that will be available to patient is tisagenlecleucel (Kymriah) as an option for treating children and young people up to 25 years old with B cell acute lymphoblastic leukaemia that is refractory, in relapsed post-transplant or in second or later relapse.</p><p> </p><p>NHS England anticipates that the National Institute for Health and Care Excellence will recommend this treatment for entry into the Cancer Drugs Fund in mid-November. If so, funding will be made immediately available, following a successful commercial deal with the manufacturer Novartis. We anticipate the first patients will begin their treatment in late November 2018. The phased implementation required by the manufacturer and the NHS means that full capacity to treat eligible patients will take some months to achieve and a National CAR-T Clinical Panel will convene in mid-November to assure equity of access and prioritise eligible patients.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 184985 question first answered 01/11/2018 16:55:17 answering member 4067 label Biography information for Steve Brine
tabling member	4249 label Biography information for Anne Marie Morris

997165

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when CAR-T therapy for adult cancer patients will be made available for patients in Torbay and Plymouth hospitals.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	184985
answer	answer is ministerial correction date of answer 01/11/2018 answer text <p>NHS England is working with the manufacturers and National Health Service providers to prepare the NHS to begin delivering Chimeric Antigen Receptor T Cell (CAR-T) therapy - the first in a wave of treatments in a new era of personalised medicine and part of the NHS’s long-term plan to upgrade cancer service. The first treatment that will be available to patient is tisagenlecleucel (Kymriah) as an option for treating children and young people up to 25 years old with B cell acute lymphoblastic leukaemia that is refractory, in relapsed post-transplant or in second or later relapse.</p><p> </p><p>NHS England anticipates that the National Institute for Health and Care Excellence will recommend this treatment for entry into the Cancer Drugs Fund in mid-November. If so, funding will be made immediately available, following a successful commercial deal with the manufacturer Novartis. We anticipate the first patients will begin their treatment in late November 2018. The phased implementation required by the manufacturer and the NHS means that full capacity to treat eligible patients will take some months to achieve and a National CAR-T Clinical Panel will convene in mid-November to assure equity of access and prioritise eligible patients.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 184984 question first answered 01/11/2018 16:55:17 answering member 4067 label Biography information for Steve Brine
tabling member	4249 label Biography information for Anne Marie Morris

997196

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people have been diagnosed with type two diabetes by (a) age and (b) gender in each clinical commissioning group area in each of the last five years.
tabling member constituency	West Bromwich East
tabling member printed	Tom Watson
uin	184908
answer	answer is ministerial correction date of answer 01/11/2018 answer text <p>Tables showing the number of people who were diagnosed with type 2 or other diabetes in each of the five calendar years 2012 to 2016 in each clinical commissioning group, by ten-year age band, and the number of people who were diagnosed with type 2 or other diabetes in each of the five calendar years 2012 to 2016 in each clinical commissioning group, by gender are attached.</p><p> </p><p>Disclosure control has been applied to all figures, as per the National Diabetes Audit publication. All numbers are rounded to the nearest five, unless the number is one to seven, in which case it is rounded to ‘five’.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 01/11/2018 16:32:37 answering member 4067 label Biography information for Steve Brine attachment 1 file name DATAPQ184908.xlsx title PQ184908 attached data
tabling member	1463 label Biography information for Lord Watson of Wyre Forest

997248

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	IVF
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that Clinical Commissioning Groups meet guidelines that IVF should be offered to women until age 42; what estimate he has made of the number of Clinical Commissioning Groups that do not meet these guidelines; and if he will make a statement.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	185122
answer	answer is ministerial correction date of answer 01/11/2018 answer text <p>Clinical commissioning groups (CCGs) should have regard to the National Institute for Health and Care Excellence (NICE) guideline on the assessment and treatment of people with fertility problems when commissioning services for which they are responsible. This includes the recommendation in the guideline that three cycles of in-vitro fertilisation be offered to qualifying couples where the woman is under the age of 40 and one cycle where the woman is between the ages of 40 and 42.</p><p> </p><p>The NICE guideline is evidence based best practice for clinicians but is not mandatory. The availability of National Health Service funded fertility treatment is matter for local determination. Decisions on the level of service provision are underpinned by clinical insight and knowledge of local healthcare needs and priorities.</p><p> </p><p>Information about the commissioning of fertility services is not collected centrally but an annual survey is undertaken by Fertility Fairness. This can be found at the following link:</p><p> </p><p><a href="http://www.fertilityfairness.co.uk/wp-content/uploads/2018/10/England-FertilityFairness_FOI_2018.pdf" target="_blank">http://www.fertilityfairness.co.uk/wp-content/uploads/2018/10/England-FertilityFairness_FOI_2018.pdf</a></p><p> </p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 01/11/2018 16:52:39 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4656 label Biography information for Layla Moran